Jiangsu Ao Si Kang Co., Ltd. has always adhered to the corporate philosophy of "scientific research as the source and health as the foundation", and has a drug research institute and a DDS research center. In 2007, it was recognized as Nanjing Enterprise Technology Center, Nanjing Anti-peptic Ulcer Drug Engineering Technology Research Center and Nanjing Industry-University-Research Research Base. The institute consists of drug synthesis room, drug analysis room, drug preparation room and innovative drug research room. The new drug research and development infrastructure is complete and the equipment is advanced. Now there are more than 10 scientific research projects every year. Since 2006, the company has applied for 45 patents, including 8 authorized invention patents. This provides the necessary guarantee for the company's development.
Jiangsu Osekang Pharmaceutical Co., Ltd. has fulfilled its social responsibilities while realizing its own development. The company has extensive cooperation and exchanges with various scientific research institutions and universities. In 2002, Jiangsu established the "Aosikang Clinical Pharmacy Fund", which successively funded a number of clinical research projects in hospitals and scientific research units in the province; Set up "Osekan Scholarship", "Osekan Scholarship" and "Osekan Research Fund" in Nanjing University of Technology to cultivate outstanding scientific research talents; Establish a cooperative relationship with pharmaceutical society and set up "Osekan Pharmaceutical Fund" to support the development of domestic pharmacy. During the Wenchuan earthquake, the company donated medicines and cash and won the "5. 12 Charity Award for Earthquake Relief" in Nanjing.